Table 3 A summary of cases with disagreement in response categories for qualitative and PERCIST evaluation with a possible clinical consequence
Qualitative evaluation | PERCIST evaluation | ||||||
|---|---|---|---|---|---|---|---|
Case | Obs. | Categories | Cons. | Reason for PMD | Obs. | Categories | Cons. |
5 | 1 | SMD/PMD | SMD | Increased uptake | 0 | ||
6 | 1 | SMD/PMD | SMD | Increased uptake | 0 | ||
7 | 1 | SMD/PMD | SMD | NA | 0 | ||
8 | 2 | PMR/PMD | PMR | New focus | 3 | PMR-PMD | PMR |
14 | 5 | PMR-PMD | PMD | New focus | 3 | PMR/PMD | PMR |
16 | 2 | SMD/PMD | PMD | Increased uptake | 1 | SMD/PMD | SMD |
20 | 1 | SMD/PMD | PMD | New focus | 3 | SMD/PMD | PMD |
21 | 1 | SMD/PMD | SMD | New focus | 1 | SMD/PMD | SMD |
28 | 1 | SMD/PMD | PMD | Increased size | 1 | SMD/PMD | SMD |
30 | 3 | PMR/PMD | PMR | New focus | 4 | PMR/PMD | PMR |
31 | 1 | SMD/PMD | SMD | Increased uptake | 0 | ||
32 | 1 | PMR/PMD | PMR | New focus | 0 | ||
33 | 4 | SMD/PMD | SMD | Increased uptake | 0 | ||
34 | 1 | SMD/PMD | PMD | Increased size | 1 | SMD/PMD | SMD |
35 | 2 | SMD/PMD | PMD | New focus | 3 | SMD/PMD | PMD |